Fast-tracking biomarker research has the potential to transform cancer diagnosis and treatment, according to a report by the University of South Australia's Sansom Institute. [ + ]

Particle & Surface Sciences (PsS) has been appointed distributor for Izon Science products across Australia. [ + ]

Stem cell researchers Mark Dawn and Jessica Mar have both received $50,000 Metcalf Prizes from the National Stem Cell Foundation of Australia. [ + ]

Australian and Sri Lankan medical researchers have forged a new action plan to investigate the causes of a particular form of chronic kidney disease. [ + ]

University of Leicester experts in association with the spin-off company MIP Diagnostics have developed polymeric materials with molecular recognition capabilities which hold the potential to outperform natural antibodies in various diagnostic applications. [ + ]

Biotron has announced that several of its compounds have demonstrated significant antiviral activity against hepatitis B (HBV) in recently completed preclinical studies. [ + ]

Prima BioMed has presented new data from a phase I clinical trial investigating eftilagimod alpha, its anticancer candidate, in combination with pembrolizumab in unresectable or metastatic melanoma patients. [ + ]

myDNA has conducted a national study into the mental health of Australians, revealing that two-thirds of people believe that improvements could be made to their medication. [ + ]

Medical and health experts from across Australia and New Zealand recently convened in Adelaide to discuss the way forward for particle therapy in Australia. [ + ]

Singaporean researchers have created polymer nanoagents that can 'light up' tiny areas of diseased tissues that conventional methods fail to detect. [ + ]

Fresh Science — an Australia-wide competition helping early-career researchers find, and then share, their stories of discovery — is now underway for 2017. [ + ]

The nominees for the 2018 NSW Australian of the Year Awards have been announced, with several scientists and inventors reaching the finals of both the Australian and Young Australian of the Year categories. [ + ]

The Zero Childhood Cancer program — said to be one of the world's most comprehensive child cancer personalised medicine studies — has finally reached Western Australia, seven weeks after its national launch. [ + ]

Scientists have reconstructed a fully functional epidermis, covering approximately 80% of the total body surface area, for a seven-year-old patient with a genetic skin disease called Junctional Epidermolysis Bullosa (JEB). [ + ]

The mechanism of how cells work is key to understanding how tumours metastasize as well as tissue regeneration and other bodily functions. [ + ]